News Headlines Article

Analyst: Stem cell agency reforms fall short
Sacramento Bee

With little money and time left to repair its legacy, California’s controversial stem cell agency is falling short in its response to a federal committee’s recommendations for an overhaul, the committee’s chair said Thursday.

The stem cell agency’s reform plan does not go far enough to fix all that has been chipping away at the agency’s credibility, said Harold Shapiro, chair of the Institute of Medicine committee hired to evaluate the agency.